892
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Stakeholders’ Ethical Concerns Regarding Psychiatric Electroceutical Interventions: Results from a US Nationwide Survey

, , , ORCID Icon & ORCID Icon

References

  • Avalere Health and Mental Health America. 2016. Shortening the road to recovery: Barriers and opportunities to improve quality of care for major depressive disorder. https://www.mhanational.org/research-reports/shortening-road-recovery-barriers-and-opportunities-improve-quality-care-major
  • Bell, E., E. Racine, P. Chiasson, M. Dufourcq-Brana, L. B. Dunn, J. J. Fins, P. J. Ford, W. Glannon, N. Lipsman, M. E. MacDonald, et al. 2014. Beyond consent in research: Revisiting vulnerability in deep brain stimulation for psychiatric disorders. Cambridge Quarterly of Healthcare Ethics: CQ: The International Journal of Healthcare Ethics Committees 23 (3):361–8. doi: 10.1017/S0963180113000984.
  • Besse, M., I. Methfessel, A. Simon, C. Wille, and D. Zilles. 2019. Electroconvulsive therapy in incapable patients refusing treatment: Prevalence, effectiveness, and associated factors. The Journal of ECT 35 (3):161–4. doi: 10.1097/YCT.0000000000000572.
  • Blease, C. 2013. Electroconvulsive therapy: The importance of informed consent and “placebo literacy. Journal of Medical Ethics 39 (3):173–4. doi: 10.1136/medethics-2012-101201.
  • Bluhm, R., E. Castillo, E. D. Achtyes, A. M. McCright, and L. Y. Cabrera. 2021. They affect the person, but for better or worse? Perceptions of electroceutical interventions for depression among psychiatrists, patients, and the public. Qualitative Health Research 31 (13):2542–53. doi: 10.1177/10497323211037642.
  • Bluhm, R., M. Cortright, E. D. Achtyes, and L. Y. Cabrera. 2023. “They are invasive in different ways.”: Stakeholders’ perceptions of the invasiveness of psychiatric electroceutical interventions. AJOB Neuroscience 14 (1):1–12. doi: 10.1080/21507740.2021.1958098.
  • Cabrera, L. Y., G. R. Nowak, A. M. McCright, E. Achtyes, and R. Bluhm. 2021a. A qualitative study of key stakeholders’ perceived risks and benefits of psychiatric ­electroceutical interventions. Health, Risk & Society 23 (5–6):217–35. doi: 10.1080/13698575.2021.1979194.
  • Cabrera, L. Y., G. R. Nowak, III, A. M. McCright, E. Achtyes, and R. Bluhm. 2021b. Last resort interventions?: A qualitative study of psychiatrists’ experience with and views on psychiatric electroceutical interventions. Psychiatric Quarterly 92 (2):419–30. doi: 10.1007/s11126-020-09819-1.
  • Cabrera, L. Y., M. Brandt, R. McKenzie, and R. Bluhm. 2019. Online comments about psychiatric neurosurgery and psychopharmacological interventions: Public perceptions and concerns. Social Science & Medicine (1982) 220 (January):184–92. doi: 10.1016/j.socscimed.2018.11.021.
  • Cabrera, L. Y., M. M. C. Gilbert, A. M. McCright, E. D. Achtyes, and R. Bluhm. 2021c. Beyond the cuckoo’s nest: Patient and public attitudes about psychiatric electroceutical interventions. The Psychiatric Quarterly 92 (4):1425–38. doi: 10.1007/s11126-021-09916-9.
  • Cabrera, L. Y., M. M. C. Gilbert, E. D. Achtyes, A. M. McCright, and R. Bluhm. 2022. Jumping through the hoops: Barriers and other ethical concerns regarding the use of psychiatric electroceutical interventions. Psychiatry Research 313:114612. doi: 10.1016/j.psychres.2022.114612.
  • Cormier, J., C. Iorio-Morin, D. Mathieu, and S. Ducharme. 2019. Psychiatric neurosurgery: A survey on the perceptions of psychiatrists and residents. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques 46 (3):303–10. doi: 10.1017/cjn.2019.5.
  • Dauenhauer, L. E., P. Chauhan, and B. J. Cohen. 2011. Factors that influence electroconvulsive therapy referrals. The Journal of ECT 27 (3):232–5. doi: 10.1097/YCT.0b013e3181f9789c.
  • Dillman, D. A., J. D. Smyth, and L. M. Christian. 2014. Internet, phone, mail, and mixed-mode surveys: The tailored design method. 4 ed. Hoboken, NY: Wiley.
  • Dobek, C. E., D. M. Blumberger, J. Downar, Z. J. Daskalakis, and F. Vila-Rodriguez. 2015. Risk of seizures in transcranial magnetic stimulation: A clinical review to inform consent process focused on bupropion. Neuropsychiatric Disease and Treatment 11:2975–87. doi: 10.2147/NDT.S91126.
  • Emerging Issues Task Force, International Neuroethics Society. 2019. Neuroethics at 15: The current and future environment for neuroethics. AJOB Neuroscience 10 (3):104–10. doi: 10.1080/21507740.2019.1632958.
  • Greely, H. T., C. Grady, K. M. Ramos, W. Chiong, J. Eberwine, N. A. Farahany, L. S. M. Johnson, B. T. Hyman, S. E. Hyman, K. S. Rommelfanger, et al. 2018. Neuroethics guiding principles for the NIH BRAIN Initiative. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 38 (50):10586–8. doi: 10.1523/JNEUROSCI.2077-18.2018.
  • Griffiths, C., and A. O’Neill-Kerr. 2019. Patients’, carers’, and the public’s persepctives on electroconvulsive therapy. Frontiers in Psychiatry 10:304. doi: 10.3389/fpsyt.2019.00304.
  • Hendriks, S., C. Grady, K. M. Ramos, W. Chiong, J. J. Fins, P. Ford, S. Goering, H. T. Greely, K. Hutchison, M. L. Kelly, et al. 2019. Ethical challenges of risk, informed consent, and posttrial responsibilities in human research with neural devices. JAMA Neurology 76 (12):1506–9. doi: 10.1001/jamaneurol.2019.3523.
  • Hermida, A. P., O. M. Glass, H. Shafi, and W. M. McDonald. 2018. Electroconvulsive therapy in depression: Current practice and future directions. The Psychiatric Clinics of North America 41 (3):341–53. doi: https://doi.org/10.1016/j.psc.2018.04.001.
  • Hoffman, S. 2018. Step therapy: Legal, ethical, and policy implications of a cost-cutting measure. Food and Drug Law Journal 73:38–65.
  • Iltis, A. S., R. Fortier, N. Ontjes, and W. V. McCall. 2023. Ethics considerations in laws restricting incapacitated patients’ access to ECT. Journal of the American Academy of Psychiatry and the Law 51 (1):47–55.
  • Johnstone, L. 1999. Adverse psychological effects of ECT. Journal of Mental Health 8 (1):69–85. doi: 10.1080/09638239917652.
  • Lawrence, R. E., C. Kaufmann, R. DeSilva, and P. S. Appelbaum. 2018. Patients’ beliefs about deep brain stimulation for treatment-resistant depression. AJOB Neuroscience 9 (4):210–8. doi: 10.1080/21507740.2018.1553897.
  • Livingston, R., C. Wu, K. Mu, and J. Coffey. 2018. Regulation of electroconvulsive therapy: A systematic review of US state laws. The Journal of ECT 34 (1):60–8. doi: 10.1097/YCT.0000000000000460.
  • Lozano, A. M., N. Lipsman, H. Bergman, P. Brown, S. Chabardès, J. W. Chang, K. Matthews, C. C. McIntyre, T. E. Schlaepfer, M. Schulder, et al. 2019. Deep brain stimulation: Current challenges and future directions. Nature Reviews. Neurology 15 (3):148–60. doi: 10.1038/s41582-018-0128-2.
  • Lutchman, R. D., T. Stevens, A. Bashir, and M. Orrell. 2001. Mental health professionals’ attitudes towards and knowledge of electroconvulsive therapy. Journal of Mental Health 10 (2):141–50. doi: 10.1080/09638230124779.
  • Magnezi, R., E. Aminov, D. Shmuel, M. Dreifuss, and P. Dannon. 2016. Comparison between neurostimulation techniques repetitive transcranial magnetic stimulation vs electroconvulsive therapy for the treatment of resistant depression: Patient preference and cost-effectiveness. Patient Preference and Adherence 10:1481–7. doi: 10.2147/PPA.S105654.
  • Mayer, G., N. Faivel, S. Aviram, G. Walter, and Y. Bloch. 2012. Repetitive transcranial magnetic stimulation in depressed adolescents. The Journal of ECT 28 (2):104–7. doi: 10.1097/YCT.0b013e318250058c.
  • McFarquhar, T. F., and J. Thompson. 2008. Knowledge and attitudes regarding electroconvulsive therapy among medical students and the general public. The Journal of ECT 24 (4):244–53. doi: 10.1097/YCT.0b013e318168be4a.
  • Muñoz, K. A., K. Kostick, C. Sanchez, L. Kalwani, L. Torgerson, R. Hsu, D. Sierra-Mercado, J. O. Robinson, S. Outram, B. A. Koenig, et al. 2020. Researcher perspectives on ethical considerations in adaptive deep brain stimulation trials. Frontiers in Human Neuroscience 14:578695. doi: 10.3389/fnhum.2020.578695.
  • Mutz, J., V. Vipulananthan, B. Carter, R. Hurlemann, C. H. Y. Fu, and A. H. Young. 2019. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: Systematic review and network meta-analysis. BMJ (Clinical Research ed.) 364:L1079. doi: https://doi.org/10.1136/bmj.l1079.
  • Park, R. J., I. Singh, A. C. Pike, and J. O. A. Tan. 2017. Deep brain stimulation in anorexia nervosa: Hope for the hopeless or exploitation of the vulnerable? The Oxford Neuroethics Gold Standard Framework. Frontiers in Psychiatry 8:44. doi: 10.3389/fpsyt.2017.00044.
  • Rasmussen, K. G. 2011. Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression. The Journal of ECT 27 (1):51–4. doi: 10.1097/YCT.0b013e3181da84c6.u.
  • Rhee, T. G., K. Sint, M. Olfson, T. Gerhard, S. H Busch, and S. T. Wilkinson. 2021. Association of ECT with risks of all-cause mortality and suicide in older Medicare patients. The American Journal of Psychiatry 178 (12):1089–97. doi: https://doi.org/10.1176/appi.ajp.2021.21040351.
  • Robertson, H., and R. Pryor. 2006. Memory and cognitive effects of ECT: Informing and assessing patients. Advances in Psychiatric Treatment 12 (3):228–37. doi: 10.1192/apt.12.3.228.
  • Rossi, S., M. Hallett, P. M. Rossini, and A. Pascual-Leone. 2009. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology: official Journal of the International Federation of Clinical Neurophysiology 120 (12):2008–39. doi: 10.1016/j.clinph.2009.08.016.
  • Rudnick, A. 2011. On the notion of (medical) invasiveness. Health Care Analysis: HCA: journal of Health Philosophy and Policy 19 (2):99–106. doi: 10.1007/s10728-010-0149-5.
  • Stern, A. P., A. D. Boes, C. S. Haller, K. Bloomingdale, A. Pascual-Leone, and D. Z. Press. 2016. Psychiatrists’ attitudes toward transcranial magnetic stimulation. Biological Psychiatry 80 (7):e55–6–e56. doi: 10.1016/j.biopsych.2015.07.027.
  • Substance Abuse and Mental Health Services Administration (SAMHSA). 2019. Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Rockville, MD.
  • Szmukler, G. 2014. When psychiatric diagnosis becomes an overworked tool. Journal of Medical Ethics 40 (8):517–20. doi: 10.1136/medethics-2013-101761.
  • Teh, S. P. C., E. Helmes, and A. G. Drake. 2007. A Western Australian survey on public attitudes toward and knowledge of electroconvulsive therapy. The International Journal of Social Psychiatry 53 (3):247–73. doi: 10.1177/0020764006074522.
  • Tørring, N., S. N. Sanghani, G. Petrides, C. H. Kellner, and S. D. Østergaard. 2017. The mortality rate of electroconvulsive therapy: A systematic review and pooled analysis. Acta Psychiatrica Scandinavica 135 (5):388–97. doi: 10.1111/acps.12721.
  • Warden, D., A. J. Rush, M. H. Trivedi, M. Fava, and S. R. Wisniewski. 2007. The STAR*D Project results: A ­comprehensive review of findings. Current Psychiatry Reports 9 (6):449–59. doi: 10.1007/s11920-007-0061-3.
  • Wilhelmy, S., V. Rolfes, M. Grözinger, Y. Chikere, S. Schöttle, and D. Groß. 2018. Knowledge and attitudes on electroconvulsive therapy in Germany: A web based survey. Psychiatry Research 262 (April):407–12. doi: 10.1016/j.psychres.2017.09.015.